CRONOS GROUP INC. Proceeds from Equity Method Investment, Distribution, Return of Capital
CRONOS GROUP INC. (CRON) reported Proceeds from Equity Method Investment, Distribution, Return of Capital of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital · last filed 2026-02-26
- CRONOS GROUP INC. proceeds from equity method investment, distribution, return of capital for the quarter ending 2024-12-31 was $0.00.
- CRONOS GROUP INC. proceeds from equity method investment, distribution, return of capital for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- CRONOS GROUP INC. proceeds from equity method investment, distribution, return of capital for the quarter ending 2023-12-31 was -$4.00K.
- CRONOS GROUP INC. proceeds from equity method investment, distribution, return of capital for the quarter ending 2023-09-30 was $2.00K.
- CRONOS GROUP INC. proceeds from equity method investment, distribution, return of capital for fiscal 2025 was $0.00.
- CRONOS GROUP INC. proceeds from equity method investment, distribution, return of capital for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- CRONOS GROUP INC. proceeds from equity method investment, distribution, return of capital for fiscal 2023 was $1.30M.
- CRONOS GROUP INC. proceeds from equity method investment, distribution, return of capital for fiscal 2022 was $0.00.
| Period end | Proceeds from Equity Method Investment, Distribution, Return of Capital 3 month | Proceeds from Equity Method Investment, Distribution, Return of Capital 6 month | Proceeds from Equity Method Investment, Distribution, Return of Capital 9 month | Proceeds from Equity Method Investment, Distribution, Return of Capital 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | |||
| 2023-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.30M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.30M 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $1.30M 10-Q · filed 2024-08-08 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |